The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Circulating Epithelial Cells in Patients with Benign Colon Diseases
Open accessAbstract
BACKGROUND: Detection of circulating tumor cells (CTCs) in the peripheral blood is a rapidly developing research field with clear clinical implications for the staging and monitoring of cancer patients. Current CTC assays, including the US Food and Drug Administration–cleared CellSearch® system, typically use markers [e.g., cytokeratins (CKs), the transmembrane protein EpCAM (epithelial cell adhesion molecule)] that are expressed on normal and malignant epithelial cells but not on the surrounding normal leukocytes. METHODS: We enrolled 53 patients with benign colon diseases (e.g., diverticulosis, benign polyps, Crohn disease, ulcerative rectocolitis, colonic endometriosis) and analyzed their peripheral blood with 2 previously validated CTC assays: the epithelial immunospot (EPISPOT) assay and the CellSearch system. The EPISPOT assay detects only viable, CK19-releasing CTCs that were enriched by depletion of CD45+ leukocytes, whereas the CellSearch system detects CK-positive CTCs after positive EpCAM-based immunomagnetic enrichment. RESULTS: In patients with benign colon diseases, positive events that met the criteria for “tumor cells” were detected with both the CellSearch system (11.3%) and the CK19-EPISPOT assay (18.9%), whereas no positive events were detected in samples from healthy volunteers. Positive events were detected most frequently in patients with diverticulosis and Crohn disease. All positive events lacked expression of CD45, a common leukocyte antigen. CONCLUSIONS: These results indicate that patients with benign inflammatory colon diseases in particular can harbor viable circulating epithelial cells that are detectable with current CTC assays. This finding points to the need for further molecular characterization of circulating epithelial cells and has important implications for the use of CTC testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Self-citationHayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., & Terstappen, L. W. W. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2821 · Cited by 1,030
Circulating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Self-citationCirculating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
Shaffer, D. R., Leversha, M. A., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Gu, B., Anand, A., Smith, K., Maslak, P., Doyle, G. V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2701 · Cited by 338
Circulating Tumor Cells and Bone Marrow Micrometastasis
Alix-Panabières, C., Riethdorf, S., & Pantel, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5125 · Cited by 244
Self-citationCell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Schwarzenbach, H., Alix-Panabières, C., Müller, I., Letang, N., Vendrell, J.-P., Rebillard, X., & Pantel, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1910 · Cited by 235
Self-citationCirculating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., García-Saenz, J. A., Vidaurreta, M., Martín, M., Arroyo, M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm583 · Cited by 215
Coumans, F. A. W., Doggen, C. J. M., Attard, G., de Bono, J. S., & Terstappen, L. W. M. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq030 · Cited by 210
Detection and Characterization of Putative Metastatic Precursor Cells in Cancer Patients
Alix-Panabières, C., Vendrell, J.-P., Pellé, O., Rebillard, X., Riethdorf, S., Müller, V., Fabbro, M., & Pantel, K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079509 · Cited by 194
Self-citationJung, R., Petersen, K. U., Krüger, W., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690778 · Cited by 156
Alix‐Panabières, C., Brouillet, J., Fabbro, M., Yssel, H., Rousset, T., Maudelondé, T., Choquet‐Kastylevsky, G., & Vendrell, J.-P. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.02.007 · Cited by 92
Self-citationAntolovic, D., Galindo, L., Carstens, A., Rahbari, N. N., Büchler, M. W., Weitz, J., & Koch, M. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-35 · Cited by 69
Detection of Circulating Prostate-Specific Antigen–Secreting Cells in Prostate Cancer Patients
Alix‐Panabières, C., Rébillard, X., Brouillet, J., Barbotte, É., Iborra, F., Segui, B., Maudelondé, T., Jolivet‐Reynaud, C., & Vendrell, J.-P. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.049445 · Cited by 60
Self-citationInsights into minimal residual disease in cancer patients: Implications for anti-cancer therapies
Müller, V., Alix‐Panabières, C., & Pantel, K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.038 · Cited by 55
Self-citation
Cited by
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Self-citationChallenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Self-citationCirculating Tumor Cells: Liquid Biopsy of Cancer
Alix-Panabières, C., & Pantel, K. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.194258 · Cited by 1,134
Self-citationLiquid Biopsy: From Discovery to Clinical Application
Alix-Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 953
Self-citationPlaks, V., Koopman, C. D., & Werb, Z. (2013) · Science · doi:10.1126/science.1235226 · Cited by 722
Metadata
- Authors
- Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J.-P., Maudelonde, T., Riethdorf, S., & Alix-Panabières, C.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-01
- Volume
- 58
- Issue
- 5
- Pages
- 936-940
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2096636873
- Cited by
- 255
- References
- 18
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.